COPAL® G+V 5184267

GUDID 04260102139862

COPAL® G+V is a standard-setting, high-viscosity, radiopaque, poly(methyl methacrylate)-based (PMMA) bone cement and designed for fixation of COPAL® exchange G hip spacer to the host bone. It contains the aminoglycoside antibiotic gentamicin and the glycopeptide antibiotic vancomycin to protect the cured bone cement and surrounding tissue from colonization by bacteria that are sensitive to gentamicin and/or vancomycin. It contains the X-ray contrast medium zirconium dioxide. To improve visibility in the surgical field, it has been colored with chlorophyll-copper-complex(E141). The bone cement consists of two components and is prepared immediately before use by mixing the polymer powder with the monomer liquid. COPAL® G+V is intended for single-use and is supplied sterile.

Heraeus Medical GmbH

Orthopaedic cement, antimicrobial Orthopaedic cement, antimicrobial Orthopaedic cement, antimicrobial Orthopaedic cement, antimicrobial Orthopaedic cement, antimicrobial Orthopaedic cement, antimicrobial Orthopaedic cement, antimicrobial Orthopaedic cement, antimicrobial Orthopaedic cement, antimicrobial Orthopaedic cement, antimicrobial Orthopaedic cement, antimicrobial Orthopaedic cement, antimicrobial Orthopaedic cement, antimicrobial Orthopaedic cement, antimicrobial Orthopaedic cement, antimicrobial Orthopaedic cement, antimicrobial Orthopaedic cement, antimicrobial
Primary Device ID04260102139862
NIH Device Record Keyb2361948-d44e-4dae-a910-d64a793de7a0
Commercial Distribution StatusIn Commercial Distribution
Brand NameCOPAL® G+V
Version Model Number1x40
Catalog Number5184267
Company DUNS333623937
Company NameHeraeus Medical GmbH
Device Count1
DM Exemptfalse
Pre-market Exemptfalse
MRI Safety StatusMR Safe
Human Cell/Tissue Productfalse
Device Kitfalse
Device Combination Producttrue
Single Usetrue
Lot Batchtrue
Serial Numberfalse
Manufacturing Datefalse
Expiration Datetrue
Donation Id Numberfalse
Contains Natural Rubber Latexfalse
Labeled No Natural Rubber Latexfalse
RX Perscriptiontrue
OTC Over-The-Counterfalse

Device Identifiers

Device Issuing AgencyDevice ID
GS104260102139855 [Primary]
GS104260102139862 [Package]
Contains: 04260102139855
Package: Carton [20 Units]
In Commercial Distribution
GS104260102139879 [Package]
Contains: 04260102139855
Package: Pallet [400 Units]
In Commercial Distribution

FDA Product Code

MBBBone Cement, Antibiotic

Sterilization

Steralize Prior To Usefalse
Device Is Steriletrue

Device Entry Metadata

Public Version StatusNew
Device Record StatusPublished
Public Version Number1
Public Version Date2024-06-18
Device Publish Date2024-06-10

Devices Manufactured by Heraeus Medical GmbH

04260102139862 - COPAL® G+V2024-06-18COPAL® G+V is a standard-setting, high-viscosity, radiopaque, poly(methyl methacrylate)-based (PMMA) bone cement and designed for fixation of COPAL® exchange G hip spacer to the host bone. It contains the aminoglycoside antibiotic gentamicin and the glycopeptide antibiotic vancomycin to protect the cured bone cement and surrounding tissue from colonization by bacteria that are sensitive to gentamicin and/or vancomycin. It contains the X-ray contrast medium zirconium dioxide. To improve visibility in the surgical field, it has been colored with chlorophyll-copper-complex(E141). The bone cement consists of two components and is prepared immediately before use by mixing the polymer powder with the monomer liquid. COPAL® G+V is intended for single-use and is supplied sterile.
04260102139862 - COPAL® G+V2024-06-18 COPAL® G+V is a standard-setting, high-viscosity, radiopaque, poly(methyl methacrylate)-based (PMMA) bone cement and designed f
04260102136694 - COPAL® exchange G2024-02-16 The COPAL® exchange G Hip and Knee Spacers devices provide patients, undergoing a two-stage revision procedure for an infected
04260102136724 - COPAL® exchange G2024-02-16 The COPAL® exchange G Hip and Knee Spacers devices provide patients, undergoing a two-stage revision procedure for an infected
04260102136755 - COPAL® exchange G 2024-02-16 The COPAL® exchange G Hip and Knee Spacers devices provide patients, undergoing a two-stage revision procedure for an infected
04260102136786 - COPAL® exchange G2024-02-16 The COPAL® exchange G Hip and Knee Spacers devices provide patients, undergoing a two-stage revision procedure for an infected
04260102136816 - COPAL® exchange G2024-02-16 The COPAL® exchange G Hip and Knee Spacers devices provide patients, undergoing a two-stage revision procedure for an infected
04260102136847 - COPAL® exchange G2024-02-16 The COPAL® exchange G Hip and Knee Spacers devices provide patients, undergoing a two-stage revision procedure for an infected
04260102136878 - COPAL® exchange G2024-02-16 The COPAL® exchange G Hip and Knee Spacers devices provide patients, undergoing a two-stage revision procedure for an infected

Trademark Results [COPAL]

Mark Image

Registration | Serial
Company
Trademark
Application Date
COPAL
COPAL
97715895 not registered Live/Pending
In Mocean Group LLC
2022-12-13
COPAL
COPAL
79225667 5663402 Live/Registered
Krzysztof Bawol
2017-08-21
COPAL
COPAL
79131038 4473176 Live/Registered
NIDEC COPAL CORPORATION
2013-04-15
COPAL
COPAL
77913448 3834767 Dead/Cancelled
Thiem, Hannah L
2010-01-16
COPAL
COPAL
77882561 not registered Dead/Abandoned
Chokron, Melanie
2009-11-30
COPAL
COPAL
77655389 not registered Dead/Abandoned
Chokron, Melanie
2009-01-23
COPAL
COPAL
76712615 4445460 Live/Registered
Heraeus Medical GmbH
2012-10-12
COPAL
COPAL
76628054 3134732 Dead/Cancelled
Heraeus Kulzer GmbH
2005-01-18
COPAL
COPAL
75642936 not registered Dead/Abandoned
Maruba Therapy, Inc.
1999-02-16
COPAL
COPAL
75416593 2228206 Dead/Cancelled
Merck KGaA, Kommanditgesellschaft auf Aktien
1998-01-12
COPAL
COPAL
75196772 not registered Dead/Abandoned
Maruba Therapy, Inc.
1996-11-12
COPAL
COPAL
74548595 1982985 Live/Registered
ADOBE INC.
1994-07-05

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.